Response by Kato et al to Letter Regarding Article, "Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus"

被引：1
|
作者：
Kato, Eri T. [1 ]
Sabatine, Marc S. [2 ]
Wiviott, Stephen D. [2 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan
[2] Brigham & Womens Hosp, Cardiovasc Div, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA
来源：
CIRCULATION | 2019年 / 140卷 / 18期
关键词：
D O I：
10.1161/CIRCULATIONAHA.119.042848
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E740 / E741
页数：2
相关论文
共 50 条
  • [31] Response by Filippatos et al to Letter Regarding Article, "Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes"
    Filippatos, Gerasimos
    Agarwal, Rajiv
    Bakris, George
    Anker, Stefan
    CIRCULATION, 2021, 144 (11) : E202 - E203
  • [32] Letter by Neumann et al Regarding Article, "Myostatin Regulates Energy Homeostasis in the Heart and Prevents Heart Failure"
    Neumann, Dietbert
    Luiken, Joost J. F. P.
    Nabben, Miranda
    Glatz, Jan F. C.
    CIRCULATION RESEARCH, 2015, 116 (10) : E95 - E96
  • [33] Letter by Mokhles et al Regarding Article, "Prosthetic Heart Valve"
    Mokhles, M. Mostafa
    Bogers, Ad J. J. C.
    Takkenberg, Johanna J. M.
    CIRCULATION, 2011, 124 (24) : E897 - E897
  • [34] Response to the letter to the editor regarding "Smoking and coronary heart disease in patients with type 2 diabetes mellitus"
    Li, Lixin
    Xu, Chun
    Wang, Ke-Sheng
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 133 : 212 - 213
  • [35] Letter by Wang and Xu Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks"
    Wang, Junfeng
    Xu, Yang
    CIRCULATION, 2019, 140 (16) : E722 - E723
  • [36] Response by Zhou et al to Letter Regarding Article, "Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure"
    Zhou, Ling
    Li, Zhuoya
    Wang, Dao Wen
    CIRCULATION, 2019, 139 (02) : 301 - 302
  • [37] Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus
    Berg, D.
    Wiviott, S.
    Scirica, B.
    Gurmu, Y.
    Mosenzon, O.
    Murphy, S.
    Bhatt, D.
    Leiter, L.
    McGuire, D.
    Wilding, J.
    Johansson, P.
    Langkilde, A.
    Raz, I.
    Braunwald, E.
    Sabatine, M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 153 - 153
  • [38] Efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus and concomitant heart failure
    Kosiborod, M.
    Gause-Nilsson, I.
    Sonesson, C.
    Johnsson, E.
    DIABETOLOGIA, 2015, 58 : S368 - S368
  • [39] Response by Aragam et al to Letter Regarding Article, "Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery"
    Aragam, Krishna G.
    Chaffin, Mark
    Ellinor, Patrick T.
    Kathiresan, Sekar
    Lubitz, Steven A.
    CIRCULATION, 2019, 140 (01) : E7 - E8
  • [40] Letter by Chen et al Regarding Article, "Heart Failure Stimulates Tumor Growth by Circulating Factors"
    Chen, Yihong
    Nilsson, Jan
    Liang, Chun
    CIRCULATION, 2019, 139 (05) : 716 - 717
12345